TrialJournal of clinical hypertension (Greenwich, Conn.)2012

Safety and efficacy of aliskiren/amlodipine/hydrochlorothiazide triple combination in patients with moderate to severe hypertension: a 54-week, open-label study.

Alexander V Murray et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.